I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. Share Yes Rinnekin - the announcement makes reference to use of the 15% placement facility - when in fact 15 m of the total new shares came from. 2. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of. Created with Sketch. 00 Days 00 Hours 00 Minutes 00 Seconds 2023 National Workshops in. Created with Sketch. ASX - By Stock. Application for quotation of securities - KZA. Market . 12% gap between the sell and buy orders now. , page-6. 1 Upvote. ASX - By Stock. Charts. Created with Sketch. MarketMEI Pharma (MEIP) rocketing in the nasdaq. Forums. Potential exhaustion levels for the current pullback are $0. Advertise on HotCopper. $0. Latest Posts. ASX - General. Forums. e. "This systematic review provides a. 3. Kazia share purchase plan, page-2. 1212. Latest Posts. 84% 5. The only contribution from KZA will be the supply of more Paxalisib. Charts. 7,123 Posts. 495 and $0. 5. Created with Sketch. Click for more information. 10:38. Advertise. . 52 would see the support line of the uptrend remain. Other Market Research Available. ASX - Day TradingKZA Price at posting: 8. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. ASX - Day TradingCreated with Sketch. ASX - By Stock. Click for more information. Created with Sketch. . , page-23. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. . 52, $0. Click for more information. 2023 National Workshops in. . HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. 0¢ Change 0. Ann: Proposed issue of securities - KZA : Thread: ASX News: 0: 252: 0: 31/10/23: 31/10/23: ASX - By Stock: Thread: Created with Sketch. As we await various study results, anyone come across research information that might help in speculating which result we may hear first and how they may. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. I know GBM AGILE recruited quickly - but simply not possible, for randomized comparison, for pax in GBM AGILE, within that timeframe. The sequential phase3 is expected to be complete in approximately 2 to 3 years. June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) : US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN. 2 MILLION Notification regarding unquoted securities - KZA. KZA PRICE PERFORMANCESince November 2021 the SP has dropped from $1. Kazia announces short term unsecured Promissory NoteTipRanks shows the blogger sentiment and article distribution of Kazia Therapeutics Ltd (AU:KZA), a biotechnology company that develops cancer treatments. 0. 0¢. Market . 42962. . Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) 's ongoing Phase 1 clinical trial tackling brain metastases, using paxalisib in combination with radiotherapy,. April 14 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT Sydney, 08 JUN 2023 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it is supporting the University of Sydney on a molecularly-guided phase II clinical study to examine paxalisib in adult patients with recurrent/progressive isocitrate dehydrogenase (IDH) mutant. 5 Upvote. 170887. This is a bit advanced, but I came across this video which discusses and shows how certain mutations in epigenetic machinery (histone tails) can lead to. . Also, Chimeric Therapeutics (ASX : CHM) are developing CAR-T cell therapy for GBM, where the cells are injected directly into the brain. . Created with Sketch. KZA Price at posting: 8. ASX - Short Term Trading. Kazia joins GBM Agile, page-3. In one embodiment the treatment provides for a reduction in PSA score, preferably a 50%, 60%, 70%, 80%, 90% or 100% reduction in PSA score. ASX - By Stock. A reversal at $0. , page-14. Market . A reversal at $0. $0. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumShare I hold my KZA shares in a Commsec SMSF account with me and my wife as the 2 directors, when this announcement was made I immediately lodged an application to open an international share trading account with Commsec and have been sitting around waiting for the paperwork to process. Forums. Latest Posts. 52, $0. On other threads the focus seems to have shifted to back and forth criticism of individual contributors and the company board and management. 27. GBM Agile Update, page-3. Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. Created with Sketch. 0¢. Target our investor community with our suite of Hotcopper Advertising opportunities. . Forums. 00% 5. Latest Posts. IPOs. 36M. Can I suggest to you, like many - you have been caught up in. Commsec just changes their US broker so we had to resubmit our US W-8 tax forms. 0000. 0219 (-2. Kazia's paxalisib granted Fast Track Designation by FDA, page-2. ASX - Short Term Trading. Kazia's anticipated Key Milestones and Newsflow schedule over the next 7. 25M. Created with Sketch. Oct 11 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA ANNOUNCES VOLUNTARY DELISTING FROM ASX KZA is an Australia-based oncology-focused drug development company that develops treatments for cancer. 5¢ KAZIA THERAPEUTICS LIMITED - Discussion. 495 and $0. , page-9. ASX - Short Term Trading. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. Kazia Therapeutics Limited (KZA), an ASX-listed company, is an oncology-focused drug development company, based in Sydney, Australia. 0¢ Change 0. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. In one embodiment, the treatment provides for an inhibition of increase in prostate specific antigen (PSA) score, or for inhibition of tumour growth. 465. . 03% when compared to the share price 7 days ago. ASX - By Stock. Good luck all. 0¢ Sentiment: Hold Disclosure: Held. ASX - Day Trading. Add KZA (ASX) to my watchlist (20min delay) Last 8. Buy your tickets now limited seats. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . Forums. ASX - Day TradingMX1 Stock Overview. Created with Sketch. ASX - By Stock. Now idelalisib which was the first to be FDA approved had the following toxicity issues "A phase II trial in patients with chronic lymphocytic leukemia found that idelalisib used as upfront therapy caused an early,. Join the HotCopper ASX share market forum today for free. ASX - Day TradingKinda a noob investor here, but just logged into my Link account after hearing the KZA news. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. Add KZA (ASX) to my watchlist. 49% 8. 20 patients in and dose cohort 6 is encouraging. , page-2. 1 Upvote. Canadian Dollar. Days Hours Minutes Seconds KZA Telehealth Solutions Center An up-to-date, comprehensive resource regarding the ever-changing telemedicine guidelines. having said that they seem very casual about anything to do with KZA- example a buy order of mine sat there for 15-20 minutes despite sellers for my volume being right on front of my nose. Latest Posts. $0. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. Kazia Corporate Presentation, page-2. Forums. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. ASX - Day Trading. Created with Sketch. 42. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forum Share Stage 1 recruitment is stopped simply because the patient cap has been reached, and not because of futility or inadequate safety. ASX - By Stock. 44 - just writing that hurts for every $1,000 dollars I should. ASX - Day TradingCompletion of recruitment to paxalisib P2 GBM studyKazia GDC-0084 SNO poster, page-5. The web page shows its share price, news, discussions, timeline and corporate information on HotCopper Forum. - unlgtd mt aprx 160 ft msl in apch zone at 3500 ft from w end of pvmt rwy 07. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . 56 to $0. ASX - Day TradingCreated with Sketch. . You won’t receive this rate. Join the HotCopper ASX share market forum today for free. You can only laugh. Our strategy identified two additional CNS penetrant experimental compounds GDC-0084 and bimiralisib. , page-2. 0 Great analysis Created with Sketch. . I haven't been able to find the details on the pre-defined criteria for moving into Stage 2. Latest Posts. But on the surface not a very pleasing read!! Expand. , page-2. )Nope just got accumulating DLS & STO for the last couple of months and things have paid off - will never replace what I missed out on SBM though (hey plough) - I just want to curl up into a ball - I was so close to slamming a large wad on them under 10c and 1 year later they are $1. ASX - Day TradingI believe we need a comprehensive shareholder briefing webinar and Q&A with management to address the accelerated non-renounceable entitlement offer as. . Created with Sketch. International Markets. ASX - By Stock. This two-day orthopaedic workshop is led by industry experts and focuses on the aspects of coding and documentation that impact your practice. ASX - Day Trading. This constitutes a price movement of 3. KZA up nearly 300% (from 250% around a couple of weeks ago) NOX at near zero 0% MSB down approx 20% KTRA (NASDAQ) down approx 90% it’s obvious Paxalisib is seen to be the superior compound So it’s very clear that Paxalisib has great support from: - our management team - our science board - our independent trial partners It is very difficult to manage a company and at the same time increase the company's share value , with the utmost respect to KZA , I feel it is time for management to hand over the reigns to a new team , who can bring renewed enthusiasm to ways of improving value to KZA share holders . ASX - By Stock. . ASX - General. Share Sounds like JG's options, maybe it was the rejection of his 0. Application for quotation of securities - KZA. Latest Posts. Feb 23 (Reuters) - Kazia Therapeutics Ltd (KZA) : LOSS FOR HALF-YEAR ATTRIBUTABLE A$13. Created with Sketch. . Just for some fun. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . . The 3rd Glioblastoma Drug Development Summit - January 18-20,. Top 20 share holdersCreated with Sketch. Forums. Kazia announces Clinical Data at ESMO 2023 from EVT801 Study In one embodiment, the treatment provides for an inhibition of increase in prostate specific antigen (PSA) score, or for inhibition of tumour growth. 8985. , page-7. ASX - By Stock. 52, $0. ASX - By Stock. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. MarketHotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. The fallacy that is spread around 'it's great that they aren't reporting on time, as patients are living longer' is just that; a fallacy!Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. HotCopper has news, discussion, prices and market data on KAZIA THERAPEUTICS LIMITED. . ASX - Day TradingChange in substantial holdingKZA agile trial which commences sometime next year is Phase 2 not Phase 3. Created with Sketch. The RPDD is granted to drugs with the potential to. Share I love paxalisib, evt801 has real potential. Physicians at the John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center have enrolled the first two patients. A $300M pa net profit would value KZA at say a multiple of 10 times for a market cap of $3B which would equate to a SP of. Like people are not interested in us,Kazia releases preliminary Cantrixil Phase I data, page-2. 5¢. 16. View the site here National Workshops More Info Webinars Watch Now Products Purchase. . Change in substantial holding. Created with Sketch. as the tweets were about) which seems to have been. Cold Comfort Ice Cream Company, Victoria, British Columbia. Comments. 52, $0. Application for quotation of securities - KZA. , page-3. Market . . March 29 (Reuters) - Kazia Therapeutics Ltd (KZA) : ENTERED INTO LICENSING AGREEMENT WITH SIMCERE PHARMACEUTICAL GROUP LTD AGREEMENT TO DEVELOP AND. Currently unlisted public company. 477 AUD for KZA. ASX - By Stock. Created with Sketch. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes for future publication. Snowflake Score. fence & road within primary sfc north side. - KZA have a market cap of only $25m - Considering it's prime drug candidate is linked with Roche - Genentech a $240b company - no buyers or interest at all - P hopper selling out atone of the most significant time in company's history - before resultsshare. 2 There is no volume. 75 yrs duration hopefully KZA will go the distance last reasonable length was 2010-2017 Helsinki Group JG is still the CEO of Kazia according to his LinkedIn profile - so he’s not been quick to update that at least. 637. Market Cap $12. 0¢ KAZIA THERAPEUTICS LIMITED - Discussion. Latest Posts. as far as our drug GDC 0084 and a number of imminent conferences. , page-2. Share Prices & Charts for KAZIA THERAPEUTICS LIMITED. 78% 17. Proposed issue of securities - KZA. be great if the FDA does consent to early marketing. 465. ZaZa Energy Corporation is an exploration and production company with primary assets in the Eagle Ford/Eaglebine Basin in Texas, and the Paris Basin in France. ASX - Short. 80. ASX - Short Term Trading. 00%) Mkt cap ! $18. . . Click for more information. Join the HotCopper ASX share market forum today for free. Including Brown. 0 Great analysis. Currently unlisted public company. ASX - By Stock. Commodities. ASX - General. ASX - Day Tradingmay 1 (reuters) - kazia therapeutics ltd (kza) : chief executive officer and managing director james garner has resigned john friend will immediately. The Company primarily explores for. ASX - Day TradingCreated with Sketch. Also. . July 6 (Reuters) - Kazia Therapeutics Ltd (KZA) : KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN. A $300M pa net profit would value KZA at say a multiple of 10 times for a market cap of $3B which would equate to a SP of. . Become a member of Australia's largest investment discussion forum. ASX - By Stock. ASX - By Stock. Share Anyone else get the sense the Nasdaq move is engineered around news from either ESMO (21/10/23) or more likely, SNO on the 16/11/23 ? In the meantime we are looking oversold. Up nearly 35% And not showing any signs Of slowing down. ASX - Day TradingCreated with Sketch. Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has been awarded a Rare Paediatric Disease Designation (RPDD) by the US Food and Drug Administration (FDA) for the use of paxalisib in the treatment of atypical rhabdoid/teratoid tumours (AT/RT), a rare and highly aggressive childhood brain cancer. 36 79993 Canadian Dollars. That's equiv. Buy your tickets now limited seats. I have roughly equal amounts invested in KZA and PAB. . Market open. , page-33. ASX - Day TradingMX1 Stock Overview. ASX - By Stock. From KZA 5th Aug release re RT/PAX trial: "Kazia expects to discuss emerging data from this study, along with other research in brain metastases, with its scientific advisors and regulatory consultants in due course, with potential FDA consultation at a future date. KZA. . 4 billion company - called ONE DAY - who is approaching the FDA for marketing approval, following a Phase 2 study in a type of childrens brain cancer, with BRAF mutations. 1 /6. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. Deep into the trial involving the KZA drug Paxalisib - any hint at all of success of drugs in this trial would be of major significance. The company's lead program is paxalisib, a brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. The Twitter/X quotes that BoroBoyinOz has just posted are very welcome but seemingly convenient. ASX - Day TradingCreated with Sketch. - KZA have a market cap of only $25m - Considering it's prime drug candidate is linked with Roche - Genentech a $240b company - no buyers or interest at all - P hopper selling out atone of the most significant time in company's history - before results share. 1. Starting a new threat for presentation of research. Join the HotCopper ASX share market forum today for free. Created with Sketch. As mentioned before. ASX - Day TradingKazia GDC-0084 SNO posterApplication for quotation of securities - KZA. Forums. ASX - By Stock. Valuation. Join the HotCopper ASX Stock discussion forum for KAZIA THERAPEUTICS LIMITED. " 31 months ago, was prior to the start of the PNOC Trial - but this story below, may explain the 2 Australian patients. While I think we're extremely busy conducting/cooperating on these 7 Clinical trials for paxalisib and finalising the Cantrixil phase 1 Clinical trial data, it may also be that we are going to venture on another molecule, perhaps a far larger commercial and. . 00%. . 03/11/23. Pure speculation but since the decline in the share price and the questionable decisions by the board and mgmt to raise money at the market likely created pressure from large institutional holders for changes. ASX - By Stock. . You need to keep everyone aligned with how trials are progressing. Valuation. International Markets. Feb 28 (Reuters) - Kazia Therapeutics Ltd (KZA) : HY LOSS AFTER INCOME TAX BENEFIT ATTRIBUTABLE A$13. Regards. Bank of New York Mellon purchase for the US Deposit Holders no doubt. Advertise. Sentiment for Kazia Therapeutics Ltd is 11. . Created with Sketch. I do hope Hotcopper keep this forum alive as I have kept some of the better grave dancing quotes. Share "first two Australian patients, now 30- and 31-months post diagnosis (continuing), effectively trebling survival. Created with Sketch. , page-2. Market . Created with Sketch. ASX - Short Term Trading. ASX - By Stock. 495 and $0. KZA is so volatile and there is a lot of trading going on (heightened volume lately). 64%) As of 09:36AM EST. Created with Sketch. Forums. Forums. . Seriously! In June the interim dipg data is July/August, then they move it to Q3, now it is November!!! The remuneration vote will make history and we. Maybe this post header could be retained for information relating to relevant info. Advertise. 495 and $0. 0¢. Folks say we are pioneers of craft ice cream in Victoria. . Market . Created with Sketch. Add KZA (ASX) to my watchlist. Alot of what you just said bmfjch. , page-35. ASX - By Stock. 52, $0. . ASX - General. Australia's largest stock trading and investment forum Australia's #1 stock forumHi James, Just a quick question regarding Cantrixil. Been. Join the HotCopper ASX share market forum today for free. Created with Sketch. . 3¢ KAZIA THERAPEUTICS LIMITED - Discussion. MX1 fundamental analysis. Well done. Cancel - Notification of cessation of securities - KZA. Last updated 15. in a post an hour ago, is simply not correct. Forums. Created with Sketch. 99M. Thought I would start a thread where we can capture external media reports, so that any potential investors can take a look on here and also to try and. . Add KZA (ASX) to my watchlist (20min delay).